FDA-Drug2015-12-16Class III
Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.
Pfizer Inc.
Hazard
Failed Dissolution Specification
Sold states
Nationwide
Affected count
a) 4005 bottles, b) 104 bottles
Manufactured in
235 East 42nd Street, N/A, New York, NY, United States
Products
Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0520-2016Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief